By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ProNAi Therapeutics, Inc. 

4717 Campus Drive
Suite 1100
Kalamazoo  Michigan  49008  U.S.A.
Phone: 269-372-3289 Fax: 269-544-1079


SEARCH JOBS








Company News
ProNAi Therapeutics, Inc. Appoints Jeffrey H. Cooper And Tran Nguyen To Its Board Of Directors 3/18/2016 6:28:07 AM
ProNAi Therapeutics, Inc. Granted Orphan Drug Designation For PNT2258 For The Treatment Of Diffuse Large B-Cell Lymphoma 3/14/2016 5:57:10 AM
ProNAi Therapeutics, Inc. Reports 2015 Year-End Financial and Operational Results 3/3/2016 10:32:21 AM
ProNAi Therapeutics, Inc. To Present At J.P. Morgan 34th Annual Healthcare Conference In San Francisco 12/22/2015 11:04:43 AM
ProNAi Therapeutics, Inc. To Present At J.P. Morgan 34th Annual Healthcare Conference In San Francisco 12/22/2015 9:40:01 AM
ProNAi Therapeutics, Inc. Added To NASDAQ Biotechnology Index 12/18/2015 7:03:02 AM
ProNAi Therapeutics, Inc. Appoints Dr. Keith Anderson And Dr. Gregg Smith To Its Senior Management Team 12/3/2015 6:58:47 AM
ProNAi Therapeutics, Inc. To Present At Jefferies Autumn 2015 Global Healthcare Conference In London 11/11/2015 10:10:43 AM
ProNAi Therapeutics, Inc. Reports Third Quarter 2015 Results 11/5/2015 10:27:58 AM
Marina Biotech, Inc. (MRNA) Reports That Licensee ProNAi Therapeutics, Inc. Initiates "Brighton" Phase II Trial Of PNT2258 In Patients With Richter's Transformation 11/4/2015 10:55:57 AM
1234
//-->